Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [31] Clustering Analysis on Patient-Physician Communication and Shared Decision-Making During Cancer Prognosis Discussion
    Li, Yikang
    Liu, Yuxuan
    Kong, Nan
    Shields, Cleveland G.
    SMART HEALTH, ICSH 2015, 2016, 9545 : 85 - 98
  • [32] Impact of Patient Mild Cognitive Impairment on Physician Decision-Making for Treatment
    Blair, Emilie
    Zahuranec, Darin
    Langa, Kenneth M.
    Forman, Jane
    Reale, Bailey K.
    Kollman, Colleen
    Giordani, Bruno
    Levine, Deborah A.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (04) : 1409 - 1417
  • [33] Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: Lessons from a qualitative pilot study
    Pozzar R.
    Baldwin L.-M.
    Goff B.A.
    Berry D.L.
    Pilot and Feasibility Studies, 4 (1)
  • [34] Patient Decision-Making Factors in Aggressive Treatment of Low-Risk Prostate Cancer
    Basak, Ramsankar
    Usinger, Deborah S.
    Chen, Ronald C.
    Shen, Xinglei
    JNCI CANCER SPECTRUM, 2022, 6 (01)
  • [35] Patient Activation and Shared Decision-Making Among Hispanics/Latinos With Metastatic Cancer: A Qualitative Study
    Meguro, Julia
    Khawand-Azoulai, Mariana
    Medina, Heidy N.
    Pons, Magela
    Huber, Michael T.
    Penedo, Frank J.
    Moreno, Patricia I.
    PSYCHO-ONCOLOGY, 2025, 34 (04)
  • [36] Patient perspectives on treatment decision-making under clinical uncertainty: chemotherapy treatment decisions among stage II colon cancer patients
    Brotzman, Laura E.
    Crookes, Danielle M.
    Austin, Jessica D.
    Neugut, Alfred, I
    Shelton, Rachel C.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2021, 11 (10) : 1905 - 1914
  • [37] Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancer
    Orr, Lisa Dwyer
    Vanderpoel, Julie
    Vadagam, Pratyusha
    Patel, Manali Indravadan
    Roy, Upal Basu
    Ledezma, Blanca
    Yung, Margaret
    Deering, Kathleen L.
    Kulbokas, Victoria
    Feldman, Josh
    Gray, Jhanelle E.
    PATIENT EDUCATION AND COUNSELING, 2025, 136
  • [38] Shared decision-making during prostate cancer consultations: Implications of clinician misalignment with patient and partner preferences
    Stewart, Simon John
    Roberts, Lisa
    Brindle, Lucy
    SOCIAL SCIENCE & MEDICINE, 2023, 329
  • [39] Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret
    Aning, J. J.
    Wassersug, R. J.
    Goldenberg, S. L.
    CURRENT ONCOLOGY, 2012, 19 : S37 - S44
  • [40] Prostate Cancer Screening Shared Decision-Making for Screening and Treatment
    Blackwelder, Russ
    Chessman, Alexander
    PRIMARY CARE, 2019, 46 (01): : 149 - +